| POLAR CAPITAL BIOTECHNOLOGY I EUR DIS | RVI BIOTECNOLOGÍA | 34,90% | 90,75% | 80,73% | 326,39% |
| GOLDMAN SACHS GLOBAL FUTURE ECONOMIC SECURITY EQUITY PORTFOLIO R USD DIS | RVI GLOBAL | 34,89% | 83,23% | · | · |
| MAN UMBRELLA SICAV - MAN TREND ALTERNATIVE DNY H EUR ACC | RENT. ABSOLUTA. VOLAT. ALTA | 34,89% | 9,30% | 16,92% | 43,29% |
| M&G (LUX) JAPAN SMALLER COMPANIES FUND EUR C ACC | RVI JAPÓN SMALL/MID CAP | 34,89% | 56,96% | 77,60% | 184,50% |
| M&G (LUX) JAPAN SMALLER COMPANIES FUND USD C ACC | RVI JAPÓN SMALL/MID CAP | 34,89% | 55,99% | 77,67% | 185,93% |
| MULTIFLEX - THE SINGULARITY FUND D1 EUR | RVI TECNOLOGÍA | 34,89% | 88,56% | 70,39% | · |
| MUTUAFONDO TECNOLOGICO, FI A | RVI TECNOLOGÍA | 34,89% | 111,02% | 111,92% | 441,53% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO P USD DIS | RVI EMERGENTES | 34,88% | 74,75% | 29,03% | 119,48% |
| RBC FUNDS (LUX)-EMERGING MARKETS EQUITY FUND S DIS USD | RVI EMERGENTES | 34,88% | · | · | · |
| BNP PARIBAS DISRUPTIVE TECHNOLOGY CLASSIC EUR DIS | RVI TECNOLOGÍA | 34,87% | 94,17% | 87,86% | 414,30% |
| FRANKLIN TECHNOLOGY A (ACC) EUR | RVI TECNOLOGÍA | 34,87% | 114,15% | 80,10% | 521,04% |
| GOLDMAN SACHS GLOBAL FUTURE ECONOMIC SECURITY EQUITY PORTFOLIO R EUR CAP | RVI GLOBAL | 34,87% | 83,68% | · | · |
| HSBC GIF GLOBAL EMERGING MARKETS EQUITY ED USD | RVI EMERGENTES | 34,87% | 73,76% | 38,05% | 104,08% |
| COBAS GRANDES COMPAÑIAS, FI A | RVI GLOBAL VALOR | 34,86% | · | · | · |
| POLAR CAPITAL BIOTECHNOLOGY I USD DIS | RVI BIOTECNOLOGÍA | 34,86% | 90,89% | 80,63% | 323,57% |
| SCHRODER ISF ASIAN OPPORTUNITIES A DIS USD | RVI ASIA EX-JAPÓN | 34,86% | 64,85% | 34,97% | 108,02% |
| SPDR MSCI WORLD VALUE UCITS ETF ACC | RVI GLOBAL VALOR | 34,86% | 73,39% | 97,81% | · |
| UBAM - POSITIVE IMPACT EMERGING EQUITY UPC USD | RVI EMERGENTES | 34,86% | 56,54% | · | · |
| CANDRIAM EQUITIES L ONCOLOGY C CAP USD | RVI SALUD | 34,85% | 31,75% | 20,66% | · |
| DWS INVEST ESG CROCI INNOVATION LEADERS USD TFC | RVI GLOBAL | 34,85% | 93,85% | 99,17% | · |
